Agenda

1. Financial Toxicity in Cancer Care
2. Leveraging Digital Technology to Improve Cancer Care Delivery
3. Health Equity in Cancer Care
4. Comprehensive Cancer Care Services
5. Alternative Payment Models

Sponsored by  

Kevin Davies, PhD, Executive Editor of The CRISPR Journal and GEN Biotechnology; Author of Editing Humanity: The CRISPR Revolution and the New Era of Genome Editing, Breakthrough: The Race for the Breast Cancer Gene, and Cracking the Genome; Co-Author of DNA: The Story of the Genetic Revolution.

The CRISPR revolution is barely ten years’ old but this astonishing genome editing technology has already earned a Nobel Prize for its developers and is having a profound impact in the clinic. Dozens of patients with sickle cell disease have been essentially cured and now this technology is being leveraged in many other genetic diseases and cancers. A growing number of therapies involve modified versions of CRISPR that are capable of precision gene editing—changing a single letter among three billion letters in the genetic code. The first FDA approval for a CRISPR therapy is imminent. But can this game-changing technology deliver safe and affordable precision medicine for patients? In this lively presentation, Dr Kevin Davies, author of Editing Humanity: The CRISPR Revolution and the New Era of Genome Editing, will discuss the origins, rivalries, breakthroughs, and scandals that have exhilarated and at times rocked the scientific and medical community. All this will be set against the backdrop of the 70th anniversary of the double helix, which we mark this spring.
More about the speaker

Danielle M. Carnival, PhD, White House Cancer Moonshot Coordinator.

New Care Delivery Models

Facilitators: Steve Grubbs, MD, Vice President of Care Delivery, American Society of Clinical Oncology (ASCO); Christine Meek, Service Line Business Manager, Munson Healthcare; Mark Liu, MHA, Senior Director of Oncology Strategy, Transformation & Analytics, Oncology Service Line, Mount Sinai Health System & Tisch Cancer Institute

A facilitated workshop that takes a deep dive into telehealth and virtual care models, alternative payment models, partnership opportunities across care settings, service line optimization, and more. Outcomes, including solutions to key challenges and actionable next steps, will be captured and used to develop a comprehensive report for meeting participants post-conference.

BI-Enabled Technology Solutions

Sponsored by  

Facilitators: Amy Ellis, Chief Operating Officer, Northwest Medical Specialties, PLLC; Douglas Flora, MD, LSSBB, Executive Medical Director, Oncology Services, St. Elizabeth Cancer Center; Jeff Hunnicutt, Chief Executive Officer, Highlands Oncology Group, PA; Matthew Manning, MD, FASTRO, Radiation Oncologist, Cone Health Cancer Center; Hugh Cassidy, PhD, MBA, Chief Data Scientist, LeanTaaS

A facilitated workshop that takes a deep dive into predictive modeling and data analytics that identify opportunities to reduce costs and improve revenue cycle management; technology platforms and AI-enabled algorithms to optimize scheduling and resource utilization; and data collection and reporting to support participation in alternative payment models, meet payer-mandated requirements, and improve social determinants of health. Outcomes, including solutions to key challenges and actionable next steps, will be captured and used to develop a comprehensive report for meeting participants post-conference .

Precision Medicine

Facilitators: Sigrun Hallmeyer, MD, Director, Cancer Institute and Cancer Survivorship Center, Advocate Lutheran General Hospital, Lutheran General Cancer Institute; Leigha Senter-Jamieson, MS, CGC, Licensed Genetic Counselor and Associate Professor, Internal Medicine, Arthur G. James Cancer Hospital and Richard J. Solove Research Institute at The Ohio State University; Emily Z. Touloukian, DO, Medical Oncologist and Hematologist and President, Coastal Cancer Center

A facilitated workshop that takes a deep dive into patient identification and navigation processes and best practices; workforce innovations, including development of new roles like precision medicine stewards and navigators; and access and policy actions to take to ensure equitable access for all. Outcomes, including solutions to key challenges and actionable next steps, will be captured and used to develop a comprehensive report for meeting participants post-conference.

Strategies to Mitigate Payer-Driven Challenges

Facilitators: Jorge García, PharmD, MS, MHA, MBA, FACHE, Assistant Vice President - System Oncology Pharmacy Service Line, Miami Cancer Institute, Baptist Health South Florida; Alti Rahman, MHA, MBA, CSSBB, Texas Society of Clinical Oncology Board Member and Practice Administrator, Oncology Consultants; Susan Sabo-Wagner, MSN, RN, OCN, Executive Director of Clinical Strategy, Oncology Consultants; Sophia Humphreys, PharmD, MHA, BCBBS, Director, System Pharmacy Formulary Management & Clinical Programs, Sutter Medical Center, Sacramento, Sutter Cancer Center

A facilitated workshop that takes a deep dive into processes to mitigate burdensome payer requirements like pre-authorizations; strategies for negotiating with payers to change policies that restrict access to care; and policy and advocacy actions to help limit payer-driven strategies like excessive step therapy protocols, use of pharmacy benefit managers, white- and brown-bagging, and policies that mandate where treatment is delivered. Outcomes, including solutions to key challenges and actionable next steps, will be captured and used to develop a comprehensive report for meeting participants post-conference.

1. Financial Toxicity in Cancer Care
2. Leveraging Digital Technology to Improve Cancer Care Delivery
3. Health Equity in Cancer Care
4. Comprehensive Cancer Care Services
5. Alternative Payment Models

Andre Harvin, PharmD, MS, MBA, Executive Director of Pharmacy, Oncology Services, Cone Health Cancer Center

While oncology is all too familiar with the skyrocketing costs of drugs and other anti-cancer treatment regimens, learn how a well-tuned pharmacy team can help your cancer program or practice realize cost savings and efficiencies with technology like robotic pharmacists, innovative biosimilar strategies, use of dose-banding, and alignment of infusion nurse and pharmacist scheduling to streamline operations and improve the patient experience.
More about the speaker

Adria Warren, Partner, Foley & Lardner LLP; Jennifer Walsh, Director, Public Affairs, Foley & Lardner LLP.

Mark Liu, MHA, Senior Director of Oncology Strategy, Transformation & Analytics, Oncology Service Line, Mount Sinai Health System & Tisch Cancer Institute; Una Hopkins, RN, FNP-BC, DNP, Director of Research, Montefiore Einstein Center Cancer Care; Ben Jones, Vice President, Government Relations & Public Policy, The US Oncology Network, McKesson

How do you plan and survive a workforce strike? Two healthcare systems share “tales from the trenches,” including the operational strategies that were put in place to keep the doors open for patients with cancer when their nurses walked out.

Sunny Levine, Senior Counsel, Foley & Lardner, LLP; Alan Einhorn, Of Counsel, Foley & Lardner LLP

Jeff Hunnicutt, Chief Executive Officer, Highlands Oncology Group, PA; Mark Liu, MHA, Senior Director of Oncology Strategy, Transformation & Analytics, Oncology Service Line, Mount Sinai Health System & Tisch Cancer Institute; Anne Marie Rainey, MSN, RN, CHC, Compliance and Quality Control Officer, Clearview Cancer Institute; Barry Russo, MHA, Chief Executive Officer, The Center for Cancer & Blood Disorders

Members of the ACCC Alternative Payment Coalition (APMC) discuss strategies for developing and operationalizing alternative payment models with private payers that will strengthen the cancer service line and then turn the discussion to a practical evaluation of the new Enhancing Oncology Model (EOM).